作者:
Arvind,Ravi [1]
;
Matthew D.,Hellmann [2]
;
Monica B.,Arniella [3]
;
Mark,Holton [4]
;
Samuel S.,Freeman [5]
;
Vivek,Naranbhai [6]
;
Chip,Stewart [7]
;
Ignaty,Leshchiner [8]
;
Jaegil,Kim [9]
;
Yo,Akiyama [10]
;
Aaron T.,Griffin [11]
;
Natalie I.,Vokes [12]
;
Mustafa,Sakhi [13]
;
Vashine,Kamesan [14]
;
Hira,Rizvi [15]
;
Biagio,Ricciuti [16]
;
Patrick M.,Forde [17]
;
Valsamo,Anagnostou [18]
;
Jonathan W.,Riess [19]
;
Don L.,Gibbons ;
Nathan A.,Pennell ;
Vamsidhar,Velcheti ;
Subba R.,Digumarthy ;
Mari,Mino-Kenudson ;
Andrea,Califano ;
John V.,Heymach ;
Roy S.,Herbst ;
Julie R.,Brahmer ;
Kurt A.,Schalper ;
Victor E.,Velculescu ;
Brian S.,Henick ;
Naiyer,Rizvi ;
Pasi A.,J?nne ;
Mark M.,Awad ;
Andrew,Chow ;
Benjamin D.,Greenbaum ;
Marta,Luksza ;
Alice T.,Shaw ;
Jedd,Wolchok ;
Nir,Hacohen ;
Gad,Getz ;
Justin F.,Gainor
作者单位:
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center
[1]
Computational Oncology, Department of Epidemiology and Biostatistics,Memorial Sloan Kettering
[2]
Department of Oncological Sciences,Icahn School of Medicine at Mount Sinai
[3]
Center for Thoracic Cancers, Massachusetts General Hospital
[4]
Weill Cornell Medicine
[5]
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard
[6]
Massachusetts General Hospital Cancer Center, Massachusetts General Hospital
[7]
AstraZeneca, Oncology R&D
[8]
GlaxoSmithKline
[9]
Herbert Irving Comprehensive Cancer Center,Columbia University
[10]
Department of Thoracic and Head and Neck Oncology,MD Anderson Cancer Center
[11]
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute
[12]
Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine
[13]
UC Davis Comprehensive Cancer Center
[14]
Department of Hematology and Medical Oncology,Cleveland Clinic
[15]
Department of Hematology and Oncology,NYU Langone Health
[16]
Department of Medicine,Harvard Medical School
[17]
Yale Cancer Center, Yale School of Medicine
[18]
Synthekine, Inc.
[19]
发布时间
2023-09-09